Onconova Therapeutics inks deal with HanX Biopharma for ON 123300 [Seeking Alpha]
Onconova Therapeutics, Inc. (ONTX)
Last onconova therapeutics, inc. earnings: 11/12 05:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.onconova.com/investor-overview
Company Research
Source: Seeking Alpha
Onconova Therapeutics inks deal with HanX Biopharma for ON 123300Onconova Therapeutics (NASDAQ:ONTX)signs a license and collaboration agreement with HanX Biopharmaceuticals for the further development and commercialization of ON 123300 in China.ON 123300 is a dual inhibitor of CDK4/6 + ARK5, which is currently in advanced preclinical development.Per the agreement, Onconova will receive milestone payments as well as royalties on Chinese sales, retaining global rights outside of China.HanX will fund studies towards Investigational New Drug applications in both the US and China.Shares are up16% premarket on light volume.See all stocks on the move »
Show less
Read more
Impact Snapshot
Event Time:
ONTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONTX alerts
High impacting Onconova Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ONTX
News
- Traws Pharma Announces New Employee Inducement Grants [Yahoo! Finance]Yahoo! Finance
- Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company [Yahoo! Finance]Yahoo! Finance
- Traws Pharma Announces New Employee Inducement GrantsGlobeNewswire
- Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology CompanyGlobeNewswire
- Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
ONTX
Earnings
- 11/14/23 - Beat
ONTX
Sec Filings
- 4/4/24 - Form 8-K
- 4/4/24 - Form DEFA14A
- 4/3/24 - Form 4
- ONTX's page on the SEC website